Melanie Farris
Compliance Officer bei TELIX PHARMACEUTICALS LIMITED
Profil
Melanie Farris is currently the Co-Chief Executive Officer at Telix Pharmaceuticals SAS.
She is also the Chairman at Synapse Australia Ltd.
In addition, she holds the position of Director at Advanced Nuclear Medicine Ingredients SA. Ms. Farris is an Associate at The Chartered Governance Institute and a Member of both the Australian Institute of Co. Directors and the Governance Institute of Australia Ltd.
She serves as the Secretary at Invion, Inc. and as the Senior VP-Global Governance, Risk & Compliance at Telix Pharmaceuticals Ltd.
In her former positions, Ms. Farris served as the Joint Secretary & Non-Executive Director at Dominion Minerals Ltd.
from 2016 to 2021.
She was also a Non-Executive Director at Invion Ltd.
from 2007 to 2020.
Additionally, she held the role of Secretary & Manager-Corporate Projects at CBio Ltd.
in 2012.
Ms. Farris completed her undergraduate degree at Griffith University.
Aktive Positionen von Melanie Farris
| Unternehmen | Position | Beginn |
|---|---|---|
| TELIX PHARMACEUTICALS LIMITED | Compliance Officer | - |
| Invion, Inc. | Unternehmenssekretär | - |
Governance Institute of Australia Ltd.
 Governance Institute of Australia Ltd. Miscellaneous Commercial ServicesCommercial Services Governance Institute of Australia Ltd. provides education, support, and networking opportunities for directors, Australian company secretaries, governance advisers, and risk managers. The private company is based in Sydney, Australia. Megan Motto has been the CEO of the company since 2019. | Corporate Officer/Principal | - |
The Chartered Governance Institute
 The Chartered Governance Institute Miscellaneous Commercial ServicesCommercial Services The Chartered Governance Institute provides governance and compliance services. The company was incorporated by Royal Charter in 1891 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - |
| Synapse Australia Ltd. | Vorsitzender | - |
Australian Institute of Co. Directors
 Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Corporate Officer/Principal | - |
Advanced Nuclear Medicine Ingredients SA
 Advanced Nuclear Medicine Ingredients SA Wholesale DistributorsDistribution Services Advanced Nuclear Medicine Ingredients SA engages in the distribution of pharmaceutical ingredients. Its products and services include toward cold kits for PET, custom peptide synthesis, new theranostic cold kits and theranostic development. The company was founded by Bruno Colard, Severine Plunus, Laurent Bodson, Monique Body, Amadeo Falcone, Sabine Lurson, Gael Minon, Michel Falcone, Vanessa Charlier, Chantal Riviere, Jean Francois Kaisin, Samuel Voccia, and Ludovic Wouters on March 27, 2015 and is headquartered in Liege, Belgium. | Direktor/Vorstandsmitglied | - |
Telix Pharmaceuticals SAS
 Telix Pharmaceuticals SAS BiotechnologyHealth Technology Telix Pharmaceuticals SAS engages in the pharmaceutical industry. It provides research in biotechnology. The company was founded on July 25, 2008 and is headquartered in Nantes, France. | Vorstandsvorsitzender | 14.04.2022 |
Ehemalige bekannte Positionen von Melanie Farris
| Unternehmen | Position | Ende |
|---|---|---|
| DOMINION MINERALS LIMITED | Direktor/Vorstandsmitglied | 01.11.2021 |
| ░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░ | ░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Melanie Farris
| Griffith University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| DOMINION MINERALS LIMITED | Non-Energy Minerals |
| INVION LIMITED | Health Technology |
| TELIX PHARMACEUTICALS LIMITED | Health Technology |
| Private Unternehmen | 8 |
|---|---|
The Chartered Governance Institute
The Chartered Governance Institute Miscellaneous Commercial ServicesCommercial Services The Chartered Governance Institute provides governance and compliance services. The company was incorporated by Royal Charter in 1891 and is headquartered in London, the United Kingdom. | Commercial Services |
CBio Ltd.
 CBio Ltd. BiotechnologyHealth Technology CBio Ltd. focuses on developing new generation products for the treatment of autoimmune and inflammatory diseases. It develops and commercializes treatments for autoimmune diseases. The company focuses and develops technologies on commercializing its proprietary drug, XToll for autoimmune and inflammatory diseases. It develops technologies for the treatment of autoimmune and inflammatory diseases. The company also engages in the business of research, product development and clinical trials of the therapeutic drug XToll and development of variants to the company's Cpn10 technology. CBio was founded by Steve P. Jones on October 11, 2000 and is headquartered at Brisbane, Australia. | Health Technology |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Commercial Services |
Governance Institute of Australia Ltd.
Governance Institute of Australia Ltd. Miscellaneous Commercial ServicesCommercial Services Governance Institute of Australia Ltd. provides education, support, and networking opportunities for directors, Australian company secretaries, governance advisers, and risk managers. The private company is based in Sydney, Australia. Megan Motto has been the CEO of the company since 2019. | Commercial Services |
Telix Pharmaceuticals SAS
Telix Pharmaceuticals SAS BiotechnologyHealth Technology Telix Pharmaceuticals SAS engages in the pharmaceutical industry. It provides research in biotechnology. The company was founded on July 25, 2008 and is headquartered in Nantes, France. | Health Technology |
| Synapse Australia Ltd. | |
Advanced Nuclear Medicine Ingredients SA
Advanced Nuclear Medicine Ingredients SA Wholesale DistributorsDistribution Services Advanced Nuclear Medicine Ingredients SA engages in the distribution of pharmaceutical ingredients. Its products and services include toward cold kits for PET, custom peptide synthesis, new theranostic cold kits and theranostic development. The company was founded by Bruno Colard, Severine Plunus, Laurent Bodson, Monique Body, Amadeo Falcone, Sabine Lurson, Gael Minon, Michel Falcone, Vanessa Charlier, Chantal Riviere, Jean Francois Kaisin, Samuel Voccia, and Ludovic Wouters on March 27, 2015 and is headquartered in Liege, Belgium. | Distribution Services |
| Invion, Inc. |
